Investing Pioneers
SUBSCRIBE NOW
  • Wall Street Word
  • Whale Tracker
  • Stocks
  • Gold
  • Crypto
  • Economy
No Result
View All Result
  • Wall Street Word
  • Whale Tracker
  • Stocks
  • Gold
  • Crypto
  • Economy
No Result
View All Result
Investing Pioneers
No Result
View All Result

Analysts Reveal Divergent Views on Colgate-Palmolive Stock

in Wall Street Word
0
0
SHARES
57
VIEWS
Share on FacebookShare on Twitter

Colgate-Palmolive Company (NYSE:CL) will release earnings results for its fourth quarter before the opening bell on Friday, Jan. 31, 2025.

Analysts expect the New York-based company to report quarterly earnings at 89 cents per share, up from 87 cents per share in the year-ago period. Colgate-Palmolive projects to report revenue of $4.99 billion for the recent quarter, compared to $4.95 billion a year earlier, according to data from Benzinga Pro.

On Dec. 11, the company’s Board of Directors declared a quarterly cash dividend of 50 cents per common share.

Colgate-Palmolive shares gained 1.5% to close at $90.89 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Stifel analyst Mark Astrachan maintained a Hold rating and cut the price target from $101 to $95 on Jan. 17, 2025. This analyst has an accuracy rate of 75%.
  • TD Cowen analyst Robert Moskow maintained a Buy rating and slashed the price target from $110 to $100 on Jan. 8, 2025. This analyst has an accuracy rate of 67%.
  • Wells Fargo analyst Chris Carey maintained an Underweight rating and lowered the price target from $92 to $83 on Jan. 7, 2025. This analyst has an accuracy rate of 61%.
  • Deutsche Bank analyst Steve Powers downgraded the stock from Buy to Hold but boosted the price target from $107 to $109 on Sept. 9, 2024. This analyst has an accuracy rate of 67%.
  • Morgan Stanley analyst Dara Mohsenian maintained an Overweight rating and increased the price target from $103 to $111 on July 29, 2024. This analyst has an accuracy rate of 70%.

Considering buying CL stock? Here’s what analysts think:

Read This Next:

  • Jim Cramer Likes This Tech Stock: ‘Terrific Business, Niche Business’
Previous Post

Top Wall Street Forecasters Revamp Phillips 66 Price Expectations Ahead Of Q4 Earnings

Next Post

Chevron Earnings Preview: Analysts Signal Mixed Outlook

Next Post

Chevron Earnings Preview: Analysts Signal Mixed Outlook

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

Boeing 777-9 Certification Update: Investor Alert

July 29, 2025

Nvidia’s Market Cap Surge: What’s Next for Investors?

July 29, 2025

Stocks to Watch as Earnings Reports Roll In

July 29, 2025

Trump’s EU Trade Deal An Act Of ‘Submission,’ Says French PM: ‘It’s A Dark Day’

July 29, 2025

Browse by Category

  • Artificial Intelligence
  • Business
  • Crypto
  • Economy
  • Gold
  • In Partnership with Preserve Gold
  • Partnership with InvestorPlace
  • Partnership with The Oxford Club
  • Personal Finance
  • Real Estate
  • Sponsored
  • Stocks
  • Tech
  • Wall Street Word
  • Whale Tracker

Recent News

Boeing 777-9 Certification Update: Investor Alert

July 29, 2025

Nvidia’s Market Cap Surge: What’s Next for Investors?

July 29, 2025
  • Privacy Policy
  • Terms of Use
  • CCPA Privacy Notice
  • SMS Terms

© 2025 - InvestingPioneers.com.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Wall Street Word
  • Whale Tracker
  • Stocks
  • Gold
  • Crypto
  • Economy

© 2025 - InvestingPioneers.com.